Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer

NCT04840472 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

28

Enrollment

OTHER

Sponsor class

Stopped tentatively suspended until drug manufacturing is available

Conditions

Head and Neck Cancer

Interventions

DRUG: 111I-n panitumumab
PROCEDURE: Single photon emission computed tomography/computed tomography (SPECT/CT) scans

Sponsor

Stanford University

Collaborators

[object Object]